Research News

Ovarian Cancer News from the European Cancer Congress

The European Cancer Congress convened in Amsterdam, the Netherlands from September 27 – October 1, 2013.  The European Cancer Congress in the main multidisciplinary and multi-professional educational meeting in oncology to take place in Europe…

Read on

Association between Marriage Status and Improved Cancer Outcomes

Research published in Sept. 2013 in the Journal of Clinical Oncology show that patients with cancer who were married at the time of diagnosis live markedly longer compared to unmarried patients…

Read on

Q&A with Ron Chandler, Ph.D.

Dr. Ron Chandler is a 2013 Ann Schreiber Mentored Investigator Award recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Chandler discusses his research and what it means to receive a grant from OCRF…

Read on

MD Anderson: Versatile microRNAs choke off cancer blood supply, suppress metastasis

A new study released today by MD Anderson Cancer Center in Texas shows that a family of microRNAs (miR-200) blocks cancer progression by cutting off the tumor’s ability to build new blood vessels…

Read on

Press Release: New Report Offers Patient Perspectives on Ovarian Cancer Treatment, Diagnosis

Washington, DC—A new report released by the Ovarian Cancer National Alliance summarizes the experiences of 1,014 women diagnosed with ovarian cancer…

Read on

Q&A with Maria Barbolina, Ph.D.

Dr. Maria Barbolina is a 2013 Liz Tilberis Early Career Award grant recipient. In this interview with OCRF’s Sarah DeFeo, Dr. Barolina discusses her research and what it means to receive a grant from OCRF…

Read on

Ovarian Tissue Transplant followed by Successful IVF Creates Future Fertility Hope for Ovarian Cancer Survivors

An ovarian cancer survivor in Australia, Vali, is 26-weeks pregnant after being told she was infertile due to ovarian cancer treatments…

Read on

OCRF Researchers Find Some Immune Cells Aid Cancer Growth

A new OCRF-funded study from researchers at the University of Michigan Comprehensive Cancer Center found that a subset of immune cells, called myeloid derived suppressor cells, do more harm than good by providing a niche where the cancer stem cells…

Read on

Helq Gene Increases Risk of Rare Ovarian Cancer

Researchers in the UK have identified a gene in mice that, if faulty, may increase the chance of developing a rare type of ovarian cancer.  The findings were published in the journal Nature…

Read on

New Index May Help to Determine Recurrence Risk

An index created at The University of Texas MD Anderson Cancer Center in Houston, based on protein biomarkers was able to discriminate between women at high risk and low risk for ovarian cancer recurrence, in a recent analysis…

Read on

Oncofertility Offers New Options for Young Women with Cancer

The Washington Post explores new options for young women going through cancer treatment who want to know about their options for having children after treatment…

Read on

Promising New Approach for Early Detection of Ovarian Cancer

Building on previously presented work, researchers at M.D. Anderson Cancer Center in Houston have published new findings that show that evaluating the change of CA-125 over time shows promise as a screening tool for early-stage ovarian cancer…

Read on